Healixa Inc.
OTC:EMOR
0.27 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.599 | 0.009 | 0 | 0.059 | 0.118 | 0.007 | 0.01 | 0.064 | 0.037 |
| Cost of Revenue
| 0.388 | 0.033 | 0.023 | 0.109 | 0.173 | 0.006 | 0.001 | 0.07 | 0.039 |
| Gross Profit
| 0.211 | -0.024 | -0.023 | -0.05 | -0.055 | 0.001 | 0.008 | -0.006 | -0.002 |
| Gross Profit Ratio
| 0.352 | -2.753 | 0 | -0.833 | -0.466 | 0.108 | 0.872 | -0.094 | -0.058 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 6.564 | 0.531 | 2.596 | 3.024 | 1.031 | 0.305 | 0.058 | 0.198 | 0.11 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 6.564 | 0.531 | 2.596 | 3.024 | 1.031 | 0.305 | 0.058 | 0.198 | 0.11 |
| Operating Income
| -6.353 | -0.555 | -2.619 | -3.074 | -1.086 | -0.304 | -0.049 | -0.204 | -0.112 |
| Operating Income Ratio
| -10.609 | -62.921 | 0 | -51.708 | -9.205 | -45.271 | -5.114 | -3.171 | -3.066 |
| Total Other Income Expenses Net
| -0.377 | -0.09 | -0.224 | -11.984 | -0.021 | -0.032 | -0 | -0.216 | -0.218 |
| Income Before Tax
| -6.73 | -0.645 | -2.843 | -15.058 | -1.107 | -0.337 | -0.05 | -0.42 | -0.331 |
| Income Before Tax Ratio
| -11.238 | -73.161 | 0 | -253.294 | -9.386 | -50.078 | -5.144 | -6.531 | -9.015 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 |
| Net Income
| -6.73 | -0.645 | -2.843 | -15.058 | -1.107 | -0.337 | -0.05 | -0.42 | -0.331 |
| Net Income Ratio
| -11.238 | -73.161 | 0 | -253.294 | -9.386 | -50.078 | -5.144 | -6.531 | -9.015 |
| EPS
| -0.009 | -0.001 | -0.004 | -0.019 | -0.001 | -0.006 | -0.001 | -0.053 | -0.068 |
| EPS Diluted
| -0.009 | -0.001 | -0.004 | -0.019 | -0.001 | -0.006 | -0.001 | -0.053 | -0.068 |
| EBITDA
| -6.32 | -0.522 | -2.596 | -2.988 | -0.997 | -0.331 | -0.048 | -0.378 | -0.309 |
| EBITDA Ratio
| -10.554 | -59.168 | 0 | -50.267 | -8.456 | -49.185 | -5.016 | -5.889 | -8.423 |